Original Research

Page 57

Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for the Treatment of Apathy in Individuals With Mild-to-Moderate Alzheimer's Disease

May 15, 2012

Laura L. Frakey, Stephen Salloway, Melissa Buelow, et al

Original Research

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

May 15, 2012

Chi-Un Pae, J. Alexander Bodkin, Kimberly Blanchard Portland, et al

Original Research

The Renin-Angiotensin Pathway in Posttraumatic Stress Disorder: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Are Associated With Fewer Traumatic Stress Symptoms

May 1, 2012

Nayla M. Khoury, Paul J. Marvar, Charles F. Gillespie, et al

Original Research

Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?

April 17, 2012

Mark Zimmerman, Jennifer A. Martinez, Naureen Attiullah, et al

Original Research

Benzodiazepine Use Possibly Increases Cancer Risk: A Population-Based Retrospective Cohort Study in Taiwan

April 15, 2012

Chia-Hung Kao, Li-Min Sun, Kuan-Pin Su, et al

Original Research

Clinical Expression of Bipolar Disorder Type I as a Function of Age and Polarity at Onset: Convergent Findings in Samples From France and the United States

April 15, 2012

Bruno Etain, Muhamed Lajnef, Frank Bellivier, et al

Original Research

Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval in the United States: Results Observed With the First 100 Consecutive Cases of Depression at an Academic Medical Center

April 15, 2012

K. Ryan Connolly, Amanda Helmer, Mario A. Cristancho, et al

Original Research

Prescribed Medication Availability and Deliberate Self-Poisoning: A Longitudinal Study

April 15, 2012

Bergljot Gjelsvik, Fridtjof Heyerdahl, Keith Hawton

Original Research

Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years: A 3-Year Open-Label Clinical Study

April 15, 2012

Robin Emsley, Petrus P. Oosthuizen, Liezl Koen, et al

Original Research

Differences Among Major Depressive Disorder With and Without Co-occurring Substance Use Disorders and Substance-Induced Depressive Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

March 20, 2012

Carlos Blanco, Analucía A. Alegría, Shang-Min Liu, et al

Original Research

New Evidence for the Involvement of Mitochondrial Inheritance in Schizophrenia: Results From a Cross-Sectional Study Evaluating the Risk of Illness in Relatives of Schizophrenia Patients

March 20, 2012

Begoña Verge, Yolanda Alonso, Carmen Miralles, et al

Original Research

Relationship Between Serum Homocysteine Levels and Depressive Symptoms: The Cooper Center Longitudinal Study

March 20, 2012

Phillip Gu, Laura F. DeFina, David Leonard, et al

Original Research

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

March 20, 2012

Robert M. Post, Gabriele S. Leverich, Lori L. Altshuler, et al

Original Research

Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial)

March 15, 2012

Anne Karow, Jens Reimer, Hans Helmut König, et al

Original Research

Prescribing Trends in Veterans With Posttraumatic Stress Disorder

March 15, 2012

Nancy C. Bernardy, Brian C. Lund, Bruce Alexander, et al

Original Research

Association of Common Variations in the Norepinephrine Transporter Gene With Response to Olanzapine-Fluoxetine Combination Versus Continued-Fluoxetine Treatment in Patients With Treatment-Resistant Depression: A Candidate Gene Analysis

March 6, 2012

John P. Houston, Kit Lau, Virginie Aris, et al

Original Research

Clozapine-Induced Agranulocytosis in Finland, 1982-2007: Long-Term Monitoring of Patients Is Still Warranted

March 6, 2012

Liisa Lahdelma, Björn Appelberg

Original Research

Co-occurrence of Serious or Undiagnosed Medical Conditions With Bipolar Disorder Preventing Clinical Trial Randomization: A Case Series

March 6, 2012

Natalie S. Feldman, Iola S. Gwizdowski, E. Grace Fischer, et al

Original Research

Effectiveness of Switching From Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres: An Open-Label, Randomized Controlled Trial

March 6, 2012

Nancy H. Covell, Joseph P. McEvoy, Nina R. Schooler, et al

Original Research

Brain-Volume Increase With Sustained Remission in Patients With Treatment-Resistant Unipolar Depression

February 21, 2012

Jennifer L. Phillips, Lisa A. Batten, Fahad Aldosary, et al

Original Research

Continued Cannabis Use and Outcome in First-Episode Psychosis: Data From a Randomized, Open-Label, Controlled Trial

February 21, 2012

Gunnar Faber, Henderikus G. O. M. Smid, Arthur R. Van Gool, et al

Original Research

Evaluation of the Glycine Transporter Inhibitor Org 25935 as Augmentation to Cognitive-Behavioral Therapy for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

February 21, 2012

Kari R. Nations, David F. Tolin, Barbara O. Rothbaum, et al

Original Research

Risks for the Transition From Major Depressive Disorder to Bipolar Disorder in the National Epidemiologic Survey on Alcohol and Related Conditions

February 21, 2012

Stephen E. Gilman, Jamie M. Dupuy, Roy H. Perlis

Original Research

Statin Use and Risk of Depression in Patients With Coronary Heart Disease: Longitudinal Data From the Heart and Soul Study

February 21, 2012

Christian Otte, Shoujun Zhao, Mary A. Whooley

« 1 … 55 56 57 58 59 … 159 »

Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for the Treatment of Apathy in Individuals With Mild-to-Moderate Alzheimer's Disease

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

The Renin-Angiotensin Pathway in Posttraumatic Stress Disorder: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Are Associated With Fewer Traumatic Stress Symptoms

Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?

Benzodiazepine Use Possibly Increases Cancer Risk: A Population-Based Retrospective Cohort Study in Taiwan

Clinical Expression of Bipolar Disorder Type I as a Function of Age and Polarity at Onset: Convergent Findings in Samples From France and the United States

Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval in the United States: Results Observed With the First 100 Consecutive Cases of Depression at an Academic Medical Center

Prescribed Medication Availability and Deliberate Self-Poisoning: A Longitudinal Study

Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years: A 3-Year Open-Label Clinical Study

Differences Among Major Depressive Disorder With and Without Co-occurring Substance Use Disorders and Substance-Induced Depressive Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

New Evidence for the Involvement of Mitochondrial Inheritance in Schizophrenia: Results From a Cross-Sectional Study Evaluating the Risk of Illness in Relatives of Schizophrenia Patients

Relationship Between Serum Homocysteine Levels and Depressive Symptoms: The Cooper Center Longitudinal Study

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial)

Prescribing Trends in Veterans With Posttraumatic Stress Disorder

Association of Common Variations in the Norepinephrine Transporter Gene With Response to Olanzapine-Fluoxetine Combination Versus Continued-Fluoxetine Treatment in Patients With Treatment-Resistant Depression: A Candidate Gene Analysis

Clozapine-Induced Agranulocytosis in Finland, 1982-2007: Long-Term Monitoring of Patients Is Still Warranted

Co-occurrence of Serious or Undiagnosed Medical Conditions With Bipolar Disorder Preventing Clinical Trial Randomization: A Case Series

Effectiveness of Switching From Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres: An Open-Label, Randomized Controlled Trial

Brain-Volume Increase With Sustained Remission in Patients With Treatment-Resistant Unipolar Depression

Continued Cannabis Use and Outcome in First-Episode Psychosis: Data From a Randomized, Open-Label, Controlled Trial

Evaluation of the Glycine Transporter Inhibitor Org 25935 as Augmentation to Cognitive-Behavioral Therapy for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Risks for the Transition From Major Depressive Disorder to Bipolar Disorder in the National Epidemiologic Survey on Alcohol and Related Conditions

Statin Use and Risk of Depression in Patients With Coronary Heart Disease: Longitudinal Data From the Heart and Soul Study

ELSEWHERE:

FOLLOW US:

Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for the Treatment of Apathy in Individuals With Mild-to-Moderate Alzheimer's Disease

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

The Renin-Angiotensin Pathway in Posttraumatic Stress Disorder: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Are Associated With Fewer Traumatic Stress Symptoms

Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?

Benzodiazepine Use Possibly Increases Cancer Risk: A Population-Based Retrospective Cohort Study in Taiwan

Clinical Expression of Bipolar Disorder Type I as a Function of Age and Polarity at Onset: Convergent Findings in Samples From France and the United States

Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval in the United States: Results Observed With the First 100 Consecutive Cases of Depression at an Academic Medical Center

Prescribed Medication Availability and Deliberate Self-Poisoning: A Longitudinal Study

Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years: A 3-Year Open-Label Clinical Study

Differences Among Major Depressive Disorder With and Without Co-occurring Substance Use Disorders and Substance-Induced Depressive Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

New Evidence for the Involvement of Mitochondrial Inheritance in Schizophrenia: Results From a Cross-Sectional Study Evaluating the Risk of Illness in Relatives of Schizophrenia Patients

Relationship Between Serum Homocysteine Levels and Depressive Symptoms: The Cooper Center Longitudinal Study

Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients

Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial)

Prescribing Trends in Veterans With Posttraumatic Stress Disorder

Association of Common Variations in the Norepinephrine Transporter Gene With Response to Olanzapine-Fluoxetine Combination Versus Continued-Fluoxetine Treatment in Patients With Treatment-Resistant Depression: A Candidate Gene Analysis

Clozapine-Induced Agranulocytosis in Finland, 1982-2007: Long-Term Monitoring of Patients Is Still Warranted

Co-occurrence of Serious or Undiagnosed Medical Conditions With Bipolar Disorder Preventing Clinical Trial Randomization: A Case Series

Effectiveness of Switching From Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres: An Open-Label, Randomized Controlled Trial

Brain-Volume Increase With Sustained Remission in Patients With Treatment-Resistant Unipolar Depression

Continued Cannabis Use and Outcome in First-Episode Psychosis: Data From a Randomized, Open-Label, Controlled Trial

Evaluation of the Glycine Transporter Inhibitor Org 25935 as Augmentation to Cognitive-Behavioral Therapy for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Risks for the Transition From Major Depressive Disorder to Bipolar Disorder in the National Epidemiologic Survey on Alcohol and Related Conditions

Statin Use and Risk of Depression in Patients With Coronary Heart Disease: Longitudinal Data From the Heart and Soul Study

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles